Cartesian Therapeutics Inc (RNAC)
10.47 x 4 12.00 x 2
Pre-market by (Cboe BZX)
11.83 -0.22 (-1.83%) 04/25/25 [NASDAQ]
10.47 x 4 12.00 x 2
Pre-market 11.83 unch (unch) 16:00 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,424 | -219,710 | 35,379 | -25,687 | -68,876 |
| Depreciation Amortization | 1,151 | 764 | 912 | 1,309 | 734 |
| Income taxes - deferred | 287 | -19,000 | N/A | N/A | N/A |
| Accounts receivable | 7,979 | 907 | 156 | -2,690 | -2,224 |
| Accounts payable and accrued liabilities | -2,927 | 2,834 | 92 | -219 | -57 |
| Other Working Capital | -5,791 | 4,971 | -60,377 | -48,194 | 85,002 |
| Other Operating Activity | 53,051 | 178,073 | -7,793 | 15,099 | 20,302 |
| Operating Cash Flow | $-23,674 | $-51,161 | $-31,631 | $-60,382 | $34,881 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 28,254 | -13,801 | -16,055 | 0 |
| PPE Investments | -8,742 | -206 | -1,201 | -1,085 | -741 |
| Net Acquisitions | N/A | 6,561 | N/A | N/A | N/A |
| Investing Cash Flow | $-8,742 | $34,609 | $-15,002 | $-17,140 | $-741 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 24,736 |
| Debt Repayment | 0 | -27,457 | N/A | N/A | -19,313 |
| Common Stock Issued | 128,494 | 231 | 39,325 | 52,897 | 3,464 |
| Other Financing Activity | 39,934 | 14,081 | -110 | 0 | 5,544 |
| Financing Cash Flow | $168,428 | $-13,145 | $39,215 | $52,897 | $14,431 |
| Exchange Rate Effect | -21 | -53 | 20 | -3 | -58 |
| Beginning Cash Position | 78,288 | 108,038 | 115,436 | 140,064 | 91,551 |
| End Cash Position | 214,279 | 78,288 | 108,038 | 115,436 | 140,064 |
| Net Cash Flow | $135,991 | $-29,750 | $-7,398 | $-24,628 | $48,513 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,674 | -51,161 | -31,631 | -60,382 | 34,881 |
| Capital Expenditure | -9,093 | -206 | -1,201 | -1,085 | -815 |
| Free Cash Flow | -32,767 | -51,367 | -32,832 | -61,467 | 34,066 |